Europium labeled lactosylated albumin as a model workflow for the development of biotherapeutics

Dimitrov, 2012 Beck, 2017, Strategies and challenges for the next generation of antibody-drug conjugates, Nat Rev Drug Discov, 16, 315, 10.1038/nrd.2016.268 Coty, 2018, Characterization of nanomedicines: a reflection on a field under construction needed for clinical translation success, J Control Release, 275, 254, 10.1016/j.jconrel.2018.02.013 National Cancer Institute, Division of Cancer Treatment and Diagnosis EUNCL Nanomedicine Characterisation Laboratory Roberts, 2014, Therapeutic protein aggregation: mechanisms, design, and control, Trends Biotechnol, 32, 372, 10.1016/j.tibtech.2014.05.005 Fekete, 2016, Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals, Anal Chem, 88, 480, 10.1021/acs.analchem.5b04561 Gahoual, 2016, Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products, J Chromatogr B Anal Technol Biomed Life Sci, 1032, 61, 10.1016/j.jchromb.2016.05.028 Berkowitz, 2012, Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars, Nat Rev Drug Discov, 11, 527, 10.1038/nrd3746 Richard, 2009, Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging, Int J Pharm, 379, 301, 10.1016/j.ijpharm.2009.05.045 Lemdani, 2018, Assessment of the targeting specificity of fluorescent albumin conceived as a preclinical agent of the liver function, Nanoscale, 10.1039/C8NR04163F Binnemans, 2015, Interpretation of europium(III) spectra, Coord Chem Rev, 295, 1, 10.1016/j.ccr.2015.02.015 Clavien, 2007, Strategies for safer liver surgery and partial liver transplantation, N Engl J Med, 356, 1545, 10.1056/NEJMra065156 Marshall, 1974, Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage, J Clin Invest, 54, 555, 10.1172/JCI107792 de Graaf, 2008, 99mTc-GSA scintigraphy with SPECT for assessment of hepatic function and functional volume during liver regeneration in a rat model of partial hepatectomy, J Nucl Med, 49, 122, 10.2967/jnumed.107.044255 Scherman, 2008 Chaumet-Riffaud, 2010, Synthesis and application of lactosylated, 99mTc chelating albumin for measurement of liver function, Bioconjug Chem, 21, 589, 10.1021/bc900275f Byegård, 1999, The stability of some metal EDTA, DTPA and DOTA complexes: application as tracers in groundwater studies, J Radioanal Nucl Chem, 241, 281, 10.1007/BF02347463 Theisen, 1999 Mizuno, 1984, Cellular distribution of the Asialoglycoprotein receptor in rat liver implications for hepatic accumulation of desialylated lymphocytes, Gastroenterology, 86, 142, 10.1016/0016-5085(84)90600-0 Zentz, 1978, Binding of galactose and lactose to ricin. Equilibrium studies, Biochim Biophys Acta, 536, 18, 10.1016/0005-2795(78)90047-8 Nakaya, 1994, Regulation of asialoglycoprotein receptor synthesis by inflammation-related cytokines in HepG2 cells, J Gastroenterol, 29, 24, 10.1007/BF01229069 Mignot, 2013, A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications, Chemistry, 19, 6122, 10.1002/chem.201203003 Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat Biotechnol, 33, 941, 10.1038/nbt.3330 Kijanka, 2014, Influence of aggregation and route of injection on the biodistribution of mouse serum albumin, PLoS One, 9, 10.1371/journal.pone.0085281 Thomas, 2017, Ultrasmall AGulX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma, Int J Nanomedicine, 12, 7075, 10.2147/IJN.S141559 Gref, 2000, “Stealth” corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids Surf B Biointerfaces, 18, 301, 10.1016/S0927-7765(99)00156-3 Hermanson, 2013, Bioconjugate techniques